Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Medical Center
With
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center
Massachusetts Institute of Technology
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults (age \> 18)
Confirmed diagnosis of Crohn's disease (CD), based on endoscopy, histology and imaging (confirmed by Study PI for each site)
Ileo-cecal resection or terminal ileal resection for CD within 30 days prior to enrollment
Resection margins \& anastomosis free of active inflammation based on histology and surgical description (confirmed by Study PI for each site)
No therapy to prevent post-operative recurrence of CD. A 30-day wash-out period for anti- tumor necrosis factors (TNF)s, thiopurines, antibiotics will be required prior to enrollment.
You may not be if
Diagnosis of indeterminate colitis
Women who are pregnant or nursing
Patients who are unable to give informed consent
Patients who are unable or unwilling to undergo colonoscopy with moderate sedation (\>ASA class II)
Patients who have previously undergone FMT
Patients who have a confirmed malignancy or cancer
Participation in a clinical trial in the preceding 30 days or simultaneously during this trial
Probiotic use within 30 days of start date
Decompensated cirrhosis
Congenital or acquired immunodeficiencies
Chronic kidney disease as defined by a GFR \<60mL/min/1.73m2 44
History of rheumatic heart disease, endocarditis, or valvular disease due to risk of bacteremia from colonoscopy
